Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Comstock Resources
CRK
$3.94B
| $1.88M | ﹤0.01% |
155,400
-34,093
| -18% | -$564K |
|
|
BRSL
1852
Brightstar Lottery PLC
BRSL
$1.86B
| $1.88M | ﹤0.01% |
101,135
+36,858
| +57% | +$785K |
|
1853
Toyota
TM
$220B
| $1.87M | ﹤0.01% |
12,140
-14,167
| -54% | -$2.34M |
|
1854
PUT
Lucid Motors
LCID
$3B
| $1.87M | ﹤0.01% |
+10,880
| New | +$2.07M |
|
1855
Kura Oncology
KURA
$816M
| $1.86M | ﹤0.01% |
101,552
+39,063
| +63% | +$562K |
|
1856
Tevogen Inc. Common Stock
TVGN
$29.6M
| $1.86M | ﹤0.01% |
3,714
| – | – |
|
|
BCPC
1857
Balchem Corp
BCPC
$5.58B
| $1.86M | ﹤0.01% |
14,317
-16,541
| -54% | -$2.07M |
|
1858
CVB Financial
CVBF
$4.03B
| $1.85M | ﹤0.01% |
74,768
-198,965
| -73% | -$4.76M |
|
1859
ARK Genomic Revolution ETF
ARKG
$1.6B
| $1.84M | ﹤0.01% |
58,405
+8,800
| +18% | +$308K |
|
|
FTAA
1860
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
| $1.84M | ﹤0.01% |
187,200
| – | – |
|
|
FPAC
1861
DELISTED
Far Peak Acquisition Corporation
FPAC
| $1.83M | ﹤0.01% |
186,619
| – | – |
|
1862
White Mountains Insurance
WTM
$5.2B
| $1.83M | ﹤0.01% |
1,469
-168
| -10% | -$195K |
|
1863
LivePerson
LPSN
$22.1M
| $1.83M | ﹤0.01% |
8,608
-8,603
| -50% | -$2.42M |
|
1864
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $1.83M | ﹤0.01% |
17,705
-2
| -0% | -$227 |
|
|
HTLF
1865
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.83M | ﹤0.01% |
43,985
-21,571
| -33% | -$949K |
|
1866
Corcept Therapeutics
CORT
$12.2B
| $1.82M | ﹤0.01% |
76,756
-35,683
| -32% | -$777K |
|
1867
Helmerich & Payne
HP
$3.41B
| $1.82M | ﹤0.01% |
42,332
-62,428
| -60% | -$2.9M |
|
|
TIGR
1868
UP Fintech Holding
TIGR
$868M
| $1.81M | ﹤0.01% |
384,332
+246,352
| +179% | +$1.05M |
|
|
ACAQ
1869
DELISTED
Athena Consumer Acquisition Corp.
ACAQ
| $1.81M | ﹤0.01% |
180,371
| – | – |
|
1870
Cabot Corp
CBT
$4.62B
| $1.81M | ﹤0.01% |
28,319
+3,076
| +12% | +$210K |
|
1871
Monro
MNRO
$399M
| $1.8M | ﹤0.01% |
42,070
-10,654
| -20% | -$476K |
|
1872
National Vision
EYE
$1.8B
| $1.8M | ﹤0.01% |
65,444
-11,287
| -15% | -$372K |
|
|
DTP
1873
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $1.8M | ﹤0.01% |
+34,931
| New | +$1.82M |
|
1874
VanEck High Yield Muni ETF
HYD
$4.42B
| $1.79M | ﹤0.01% |
+33,300
| New | +$1.82M |
|
1875
Goodyear
GT
$2.02B
| $1.79M | ﹤0.01% |
167,197
+25,274
| +18% | +$317K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.